HYML-122; cytarabine Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

Tarapeutics Science Inc.1

Indications

Relapsed or Refractory Acute Myeloid Leukemia (AML)1
Cancer1

Other1 trial

A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.